Abstract:Objectives Multiple warfarin pharmacogenetic algorithms have been published and been confirmed to predict warfarin dose more accurately than clinical algorithm or fixed-dose approach. However, their performance in Chinese patients has never been evaluated. We sought to compare the performance of published warfarin pharmacogenetic algorithms in a cohort of Chinese patients under warfarin anticoagulation. Methods The study population consisted of 282 unrelated Han-Chinese patients consecutively admitted to the General Hospital of Chinese People9s Liberation Army between January 2008 and July 2011. The patients had all undergone warfarin anticoagulation for various indications and were stably controlled with a target international normalisation ratio (INR) of 1.6–2.5. Genomic DNA extraction from each patient was followed by genotyping to detect the polymorphisms of CYP2C9*3 (rs1057910), VKORC1 −1639 G/A (rs9923231), and CYP4F2*3 (rs2108622) respectively, using standard techniques. A total of 8 eligible pharmacogenetic algorithms were selected for performance comparison. The performance of each algorithm was evaluated by calculating the percentage of patients whose predicted dose fell within 20% of their actual therapeutic dose (percentage within 20%), and the mean absolute error (MAE) between each predicted dose and actual stable dose. Results In the entire cohort, the pharmacogenetic algorithms could predict warfarin dose with the average MAE of 0.87±0.17 mg/day (0.73–1.17 mg/day), and the average percentage within 20% of 43.8%±8.1% (29.1–52.1%). By pair wise comparison, warfarin dose prediction was significantly more accurate with the algorithms derived from Asian patients (48.6–50.0%) than those from Caucasian patients (29.1–39.7%; OR 1.61–3.36, p≤0.02). Algorithms with additional covariates of INR values or CYP4F2*3 performed better than those without the covariates (adding INR: OR: 1.71 (1.08–2.72), p=0.029; adding CYP4F2*3: OR: 2.67 (1.41–5.05), p=0.004). When the patients were stratified according to the dose range, the algorithms from Caucasian and racially mixed populations tended to perform better in higher dose group (≥4.5 mg/day), and algorithms from Asian populations performed better in intermediate dose group (1.5–4.5 mg/day). None of the algorithms performed well in lower dose group (≤1.5 mg/day). Conclusions Our study indicated that none of the eligible pharmacogenetic algorithms could perform the best for all dosing ranges in the present cohort of Chinese patients under warfarin anticoagulation. It may be important to consider the ethnic and clinical specific characteristics when choosing the appropriate algorithm for a local service population. A more refinement pharmacogenetic algorithm combining 3 genotypes (CYP2C9, VKORC1 and CYP4F2) and clinical factors with INR response could potentially improve the warfarin dose prediction in Chinese patients.

To Establish a Model for the Prediction of Initial Standard and Maintenance Doses of Warfarin for the Han Chinese Population Based on Gene Polymorphism: a Multicenter Study

Establishment of clinical drug dosage computation model based on the Warfarin dosage associated genes

Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

Genetic factors contribute to patient-specific warfarin dose for Han Chinese.

Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method

Effects of CYP2C9 and VKORC1 Genetic Polymorphisms in Chinese Han Population on Maintenance Dosage of Warfarin

Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm.

Warfarin Dosage Response Related Pharmacogenetics In Chinese Population

Establishment and evaluation of a warfarin-dosing algorithm in Chinese Han population

Identification of Two Novel Genes SLC15A2 and SLCO1B3 Associated with Maintenance Dose Variability of Warfarin in a Chinese Population

Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX Polymorphisms on Warfarin Maintenance Dose: Exploring a New Algorithm in South Chinese Patients Accept Mechanical Heart Valve Replacement

[Clinical Applications of Dosing Algorithm in the Predication of Warfarin Maintenance Dose].

Comparative Performance of Gene-Based Warfarin Dosing Algorithms in Chinese Patients

Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients

Estimation of the Warfarin Dose with A Pharmacogenetic Refinement Algorithm in Chinese Patients Mainly under Low-Intensity Warfarin Anticoagulation

Construction and Validation of A Pharmacogenetic Refinement Algorithm for the Estimation of the Warfarin Dose in Chinese Patients

To Establish a Method for Detecting Genetic Polymorphism of CYP2C9 1075A>C and VKORC1-1639 G>A and Evaluate the Correlation of SNP with Warfarin Dose

Validation Of Vkorc1 And Cyp2c9 Genotypes On Interindividual Warfarin Maintenance Dose: A Prospective Study In Chinese Patients

[Impact of Five Genetic Polymorphisms on Inter-Individual Variation in Warfarin Maintenance Dose].